Search results for: 'share size of computer'

17 Aug 2020  |  North America  |  Market Research

On-demand Manufacturing Propels the Global Dimensional Metrology Equipment Market for Additive Manufacturing

Future Market Prospects Enhanced by Growth Opportunities in Medical and Electronics Additive Manufacturing

Infographics

×

This Frost & Sullivan research service analyzes the global dimensional metrology market for additive manufacturing in detail for the period from 2018 to 2024, with 2019 as the base year. The study covers key advanced technologies, including optical microscopes, scanning electron microscopes, coordinated measuring machines (CMM), 3D scanning, X-ray ...

Pharmaceutical drug discovery and development suffers from declining success rates with new molecules, and the rate of return has shrunk from 16% in 2011 to almost 11% in 2018. Frost & Sullivan finds that traditional solutions focused primarily on data from limited sources and rule-based computational techniques used to address the understanding of...

In H1 2018, Frost & Sullivan’s ICT team conducted a small-scale survey of thought leaders from around the world to seek opinion on the technologies that will have a profound transformative impact on existing industry dynamics, value chains, and business models across multiple vertical markets in the next 10 years. Survey respondents came from two ...

Nanophotonics is the science of controlling light generation, manipulation, transport, and detection on ultra-small length scales. It is an emerging technology that involves the interaction of light with structures smaller than approximately 100nm. The technology has a far-reaching application landscape, and photovoltaics and displays are likely...

25 Apr 2022  |  North America  |  Frost Radar

Frost Radar™: Artificial Intelligence-enabled Drug Discovery, 2022

A Benchmarking System to Spark Companies to Action - Innovation that Fuels New Deal Flow and Growth Pipelines

Infographics

×

Pharmaceutical drug discovery and development has been suffering from declining success rates with new molecules primarily because of poor external validity of preclinical models and lack of efficacy of the molecule in terms of the intended disease indication. Drug success rates continue to be in the range of only 1 in 10 that enters clinical phase...

This edition of the Cyber Security Technology Opportunity Engine (TOE) captures developments related to Zero-trust and Secure Remote Access , Asset Intelligence and Protection, Advanced Threat Protection, Cloud Security, Security Pentesting. Cyber Security TOE’s mission is to investigate new and emerging developments that aim to protect the network...

This edition of the Cyber Security Technology Opportunity Engine (TOE) captures developments related to Innovations in AI, Cloud and Network Security, Threat and Behavioural Intelligence, Risk and Vulnerability Assessment, Access Control, Blockchain Security. Cyber Security TOE’s mission is to investigate new and emerging developments that aim to p...

This edition of the Cyber Security Technology Opportunity Engine (TOE) captures developments related to Innovations in Incident Response and Detection, AI-based Cybersecurity, Zero Trust Security, Observability Platform, Vulnerability Management, Documentation Security Assessments, Quantum-safe Cryptography, Predictive Vulnerability Assessment. Cy...

This edition of the Cyber Security Technology Opportunity Engine (TOE) captures developments related to Innovations in Incident Zero knowledge encryption, Endpoint security and management solutions, AI-SIEM platform, Social media security, Predictive security intelligence, Multi-Factor Authentication (MFA), AI-powered Defense. Cyber Security TOE’s ...